HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuropeptide K: a major tachykinin in plasma and tumor tissues from carcinoid patients.

Abstract
Evidence is presented for the presence of an entire family of tachykinin-immunoreactive peptides in plasma and tumor tissues from patients with carcinoid tumors. The peptides include in addition to substance P and neurokinin A; neurokinin B, an eledoisin like peptide and neuropeptide K--a 36 amino acid long tachykinin which contains neurokinin A at its C-terminus. Neuropeptide K seems to be the tachykinin which is present in highest concentrations in plasma as well as in acetic acid extracts of tumor tissues. It is highly biologically active, and may therefore contribute to the clinical symptoms of carcinoid tumors.
AuthorsE Theodorsson-Norheim, I Norheim, K Oberg, E Brodin, J M Lundberg, K Tatemoto, P G Lindgren
JournalBiochemical and biophysical research communications (Biochem Biophys Res Commun) Vol. 131 Issue 1 Pg. 77-83 (Aug 30 1985) ISSN: 0006-291X [Print] United States
PMID2412557 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nerve Tissue Proteins
  • Oligopeptides
  • Tachykinins
  • neuropeptide K
  • Substance P
  • Eledoisin
  • Neurokinin A
  • Neurokinin B
Topics
  • Carcinoid Tumor (blood, metabolism)
  • Chromatography, High Pressure Liquid
  • Chromatography, Ion Exchange
  • Eledoisin (metabolism)
  • Humans
  • Immunoassay
  • Nerve Tissue Proteins (blood, metabolism)
  • Neurokinin A
  • Neurokinin B
  • Oligopeptides (metabolism)
  • Substance P (metabolism)
  • Tachykinins

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: